Results 361 to 370 of about 411,291 (407)
Some of the next articles are maybe not open access.
Percutaneous coronary intervention in the elderly
Nature Reviews Cardiology, 2010In contemporary practice, more than one in five patients treated with percutaneous coronary intervention (PCI) are aged ≥75 years and the proportion of elderly individuals in the population is growing. The elderly have more cardiovascular risk factors and a greater burden of ischemic disease than younger patients needing PCI and, therefore, derive ...
Antonio Gutierrez+2 more
openaire +3 more sources
Percutaneous coronary intervention in the elderly
International Journal of Cardiology, 2015Our population dynamics are changing. The number of octogenarians and older people in the general population is increasing and therefore the number of older patients presenting with acute coronary syndrome or stable angina is increasing. This group has a larger burden of coronary disease and also a greater number of concomitant comorbidities when ...
Sunil K. Nadar, Kully Sandhu
openaire +3 more sources
Percutaneous Intervention of Coronary Aneurysm
Cardiovascular Revascularization Medicine, 2020The coronary artery aneurysm (CAA) is not a frequent condition in the catheterization laboratory. The management is uncertain. Most of the cases, the treatment is surgical with good results. In smaller aneurysm, the use of covered stents is an alternative. This is an anterograde approach CTO (chronic total occlusion) case of a middle segment RCA (right
Rodrigo Monsalve+6 more
openaire +3 more sources
Tachyarrhythmias in percutaneous coronary interventions [PDF]
Accompanying the clear benefits, there are certain risks of tachyarrhythmias in percutaneous coronary interventions (PCI), including serious ventricular arrhythmias and atrial fibrillation (AF). Ventricular arrhythmias may result from excess catheter manipulation, intracoronary dye injection, new ischemic events, or reperfusion.
openaire +2 more sources
Bivalirudin in percutaneous coronary intervention
American Journal of Health-System Pharmacy, 2003The chemistry and pharmacology, pharmacokinetics, pharmacodynamics, adverse effects, drug interactions, dosing and administration, and pharmacoeconomics of bivalirudin are reviewed; clinical trials of bivalirudin's application in percutaneous coronary intervention (PCI) are also discussed.
George R. McKendall, Michael F. Caron
openaire +3 more sources
Advances in percutaneous coronary intervention
Current Cardiology Reports, 2009Initially developed more than 30 years ago as simple balloon-based dilatation for focal coronary stenoses, the introduction of the coronary stent allowed percutaneous coronary intervention (PCI) to be applied to most patients with coronary artery disease.
Gregg W. Stone, Somjot S Brar
openaire +3 more sources
Circulation. Cardiovascular Interventions, 2019
BACKGROUND Recently, the Academic Research Consortium for High Bleeding Risk (ARC-HBR) has been proposed to standardize the definition of HBR, which was arbitrarily defined as a Bleeding Academic Research Consortium 3 or 5 bleeding ≥4% at 1-year. However,
M. Natsuaki+14 more
semanticscholar +1 more source
BACKGROUND Recently, the Academic Research Consortium for High Bleeding Risk (ARC-HBR) has been proposed to standardize the definition of HBR, which was arbitrarily defined as a Bleeding Academic Research Consortium 3 or 5 bleeding ≥4% at 1-year. However,
M. Natsuaki+14 more
semanticscholar +1 more source
P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention
Nature Reviews Cardiology, 2022D. Capodanno+23 more
semanticscholar +1 more source
Percutaneous Coronary Intervention
2009A 77-year-old woman presented with a history of chest pain, subsequent to percutaneous coronary intervention (PCI).
openaire +2 more sources
European Heart Journal, 2018
AIMS This study aims to examine the temporal trends and outcomes in patients who undergo percutaneous coronary intervention (PCI) with a previous or current diagnosis of cancer, according to cancer type and the presence of metastases.
Jessica Potts+10 more
semanticscholar +1 more source
AIMS This study aims to examine the temporal trends and outcomes in patients who undergo percutaneous coronary intervention (PCI) with a previous or current diagnosis of cancer, according to cancer type and the presence of metastases.
Jessica Potts+10 more
semanticscholar +1 more source